Dianthus Therapeutics

DNTH

Market cap $1.42B

Overview Fund Trends Analyst Outlook Journalist POV

Buy

Hold

Sell

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$67

88% upside

High target

8 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Truist Securities Danielle Brill 100% 1-yr DNTH win rate				14 Oct ‘25 3 days ago
Clear Street Bill Maughan 0% 1-yr DNTH win rate				17 Sep ‘25 1 month ago
Stifel Alex Thompson 0% 1-yr DNTH win rate				12 Sep ‘25 1 month ago
Wedbush Laura Chico 50% 1-yr DNTH win rate				12 Sep ‘25 1 month ago
Raymond James Steve Seedhouse 100% 1-yr DNTH win rate				9 Sep ‘25 1 month ago
Guggenheim Yatin Suneja 100% 1-yr DNTH win rate				9 Sep ‘25 1 month ago
Baird Joel Beatty 100% 1-yr DNTH win rate				9 Sep ‘25 1 month ago
HC Wainwright & Co Swayampakula Ramakanth 50% 1-yr DNTH win rate				8 Sep ‘25 1 month ago